HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 293 filers reported holding HAEMONETICS CORP in Q2 2018. The put-call ratio across all filers is 13.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $1,366,000 | -37.8% | 18,675 | -50.6% | 0.01% | -38.5% |
| Q4 2017 | $2,195,000 | +31.5% | 37,800 | +1.6% | 0.01% | +30.0% |
| Q3 2017 | $1,669,000 | +8.4% | 37,200 | -4.6% | 0.01% | +11.1% |
| Q2 2017 | $1,539,000 | -25.9% | 38,975 | -23.9% | 0.01% | -25.0% |
| Q1 2017 | $2,077,000 | +11.4% | 51,200 | +10.3% | 0.01% | 0.0% |
| Q4 2016 | $1,865,000 | +14.6% | 46,405 | +3.3% | 0.01% | +20.0% |
| Q3 2016 | $1,627,000 | +23.9% | 44,925 | -0.8% | 0.01% | +11.1% |
| Q2 2016 | $1,313,000 | -19.4% | 45,300 | -2.8% | 0.01% | -18.2% |
| Q1 2016 | $1,630,000 | +6.5% | 46,600 | -1.9% | 0.01% | +10.0% |
| Q4 2015 | $1,531,000 | +8.1% | 47,500 | +8.4% | 0.01% | 0.0% |
| Q3 2015 | $1,416,000 | -4.9% | 43,800 | +21.7% | 0.01% | 0.0% |
| Q2 2015 | $1,489,000 | -9.5% | 36,000 | -1.7% | 0.01% | -9.1% |
| Q1 2015 | $1,645,000 | +71.5% | 36,630 | +42.9% | 0.01% | +83.3% |
| Q4 2014 | $959,000 | -84.4% | 25,630 | -82.7% | 0.01% | -73.9% |
| Q1 2013 | $6,156,000 | -44.8% | 147,782 | -45.9% | 0.02% | -47.7% |
| Q4 2012 | $11,158,000 | – | 273,220 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LGT CAPITAL PARTNERS LTD. | 1,216,059 | $64,500,000 | 1.72% |
| HEARTLAND ADVISORS INC | 406,192 | $21,544,000 | 1.26% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 200,000 | $10,608,000 | 1.22% |
| Aurora Investment Counsel | 32,149 | $1,705,000 | 1.01% |
| Endurant Capital Management LP | 73,914 | $3,920,000 | 0.95% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 135,000 | $7,160,000 | 0.82% |
| ARMISTICE CAPITAL, LLC | 872,000 | $46,251,000 | 0.76% |
| Summit Creek Advisors LLC | 131,357 | $6,967,000 | 0.70% |
| Dean Capital Management | 15,309 | $812,000 | 0.70% |
| Keene & Associates, Inc. | 11,720 | $622,000 | 0.54% |